| Inherited Arrhythmia |
| 01-30 | 10:40-12:20 | N104-105 | Session: | Approach to Genetic Testing for Heritable Arrhythmias: How to … | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Heritability patterns of early repolarization syndrome | | |
| Topic 2. | PRKAG2 Cardiac Syndrome | | |
| Topic 3. | How to approach the results of genetic testing in sudden death patients | | |
| Topic 4. | How to counsel patients with children following genetic testing | | |
| Topic 5. | Optimizing the yield of genetic testing: Avoiding unnecessary testing | | |
| Topic 6. | IL6R polymorphisms and risk of atrial fibrillation | | |
| ICD |
| 01-30 | 10:40-12:20 | N106-107 | Session: | ICD Implant Related Issues | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | Morbidity and mortality impact of ICD therapy: short and long term | | |
| Topic 2. | Implanting to minimize complications | | |
| Topic 3. | When and how to test defibrillation | | |
| Topic 4. | Incidence, recognition and therapy of ICD infections | | |
| Topic 5. | Follow leads with and without reliability issues | | |
| Oral Abstract Session |
| 01-30 | 10:40-12:20 | N108 | Session: | Atrial Fibrillation (Ablation) 1 | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Remote Monitoring |
| 01-30 | 10:40-12:20 | N109-110 | Session: | Remote Monitoring and Sensors | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Who benefits from hemodynamic monitoring and CRT optimization | | |
| Topic 2. | Role of remote monitoring to manage ventricular tachyarrhythmias in heart failure patients | | |
| Topic 3. | Implantable pressure sensors | | |
| Topic 4. | Impedance and other sensors | | |
| Atrial Fibrillation Ablation |
| 01-30 | 10:40-12:20 | N111-112 | Session: | Catheter Ablation of Atrial Fibrillation: State of the Art | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | The scientific basis of AF ablation: why does it work? | | |
| Topic 2. | Catheter ablation of paroxysmal atrial fibrillation current technique, success, and complications | | |
| Topic 3. | Catheter ablation of long standing persistent atrial fibrillation current technique, success, and complications | | |
| Topic 4. | Mapping rotors: scientific interest or clinical tool | | |
| Topic 5. | Guideline recommendations for AF ablation: what is new? | | |
| HF Device & Monitoring |
| 01-30 | 13:50-15:30 | N104-105 | Session: | Optimization of CRT | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | Impact of QRS duration and morphology on CRT effectiveness | | |
| Topic 2. | Effect of lead position on clinical outcome | | |
| Topic 3. | RV function in CRT | | |
| Topic 4. | Novel LV lead placement | | |
| Topic 5. | Role of MRI for CRT | | |
| Atrial Fibrillation Epidemiology |
| 01-30 | 13:50-15:30 | N106-107 | Session: | AF Epidemiology: Asian Perspective | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | AF in Hong Kong | | |
| Topic 2. | AF in Singapore | | |
| Topic 3. | AF in Korea | | |
| Topic 4. | AF in GULF | | |
| Topic 5. | AF in Taiwan | | |
| Topic 6. | AF in Thailand | | |
| Oral Abstract Session |
| 01-30 | 13:50-15:30 | N108 | Session: | Ablation VT/SVT | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| CRT |
| 01-30 | 13:50-15:30 | N109-110 | Session: | CRT Workshop 1 | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | Where to place the RV lead | | |
| Topic 2. | Role of echo to guide LV lead placement | | |
| Topic 3. | Benefit of quadripolar LV leads | | |
| Atrial Fibrillation Ablation |
| 01-30 | 13:50-15:30 | N111-112 | Session: | Technical Aspects of Ablation Tools | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | How to maximize the value of force sensing ablation catheters | | |
| Topic 2. | Value and pitfalls of image integration | | |
| Topic 3. | How to identify rotors? | | |
| Topic 4. | How to maximize the value of ICE imaging? | | |
| Topic 5. | How to prevent an atrial esophageal fistula? | | |
| ECG |
| 01-30 | 16:00-17:40 | N101A | Session: | Advanced Electrocardiography | |
| Panelists | , | | |
| | , | | |
| | , | | |
| | , | | |
| | , | | |
| HF Device & Monitoring |
| 01-30 | 16:00-17:40 | N104-105 | Session: | Advances in CRT Therapy | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Expanding indications of CRT | | |
| Topic 2. | Left ventricular endocardial leadless pacing | | |
| Topic 3. | Predictors of mortality and cardiovascular mortality after CRT | | |
| Topic 4. | Electromechanical guidance to CRT | | |
| Topic 5. | Antiarrhythmic effects of CRT with triple biventricular stimulation | | |
| Oral Abstract Session |
| 01-30 | 16:00-17:40 | N108 | Session: | Sudden Cardiac Death / Tachycardia Therapy Device | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Syncope |
| 01-30 | 16:00-17:40 | N109-110 | Session: | Hot Topics in Syncope | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Syncope: when to worry? | | |
| Topic 2. | Appropriate tests for syncope | | |
| Topic 3. | Orthostatic hypotension as a cause of syncope in the elderly | | |
| Topic 4. | Causes of transient loss of consciousness and assessment of need for hospitalization | | |
| Topic 5. | Cardiac pacing for vasovagal syncope | | |
| Atrial Fibrillation Epidemiology |
| 01-30 | 16:00-17:40 | N111-112 | Session: | Stroke Prevention for AF in Asian populations | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | LAAO in Asian populations | | |
| Topic 2. | Warfarin therapy for AF in Asian | | |
| Topic 3. | Overview of current AF guidelines | | |
| Topic 4. | Triple therapy for Asian AF patients with CAD | | |
| Topic 5. | NOAC for SPAF in Asia | | |
| Special Session |
| 01-30 | 16:00-17:40 | N111-112 | Session: | Sudden Cardiac Death Symposium (Supported by unrestricted grant from Hong Kong Heart Foundation & Wei Lun Foundation Ltd.) | |
| Panelists | , | | |
| | , | | |
| | , | | |
| | , | | |
| | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | Rising burden of pulseless electrical activity: causes and implications | | |
| Topic 2. | Following acute myocardial infarction | | |
| Topic 3. | In non-ischemic cardiomyopathy | | |
| Topic 4. | Assessing risk of SCD in the young athlete | | |
| Topic 5. | Exercise presccription for patients at established high risk | | |
| Sponsored Symposium |
| 01-30 | 18:00-19:45 | N101A | Session: | Merck Sharp & Dohme Cocktail Reception & Evening Symposium | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Cocktail Reception | | |
| Topic 2. | Sharing the APHRS guideline on anticoagulation in AF | | |
| Topic 3. | Lowering CV risk - how low can you go? | | |
| Topic 4. | Panel discussion | | |
| Sponsored Symposium |
| 01-30 | 18:30-20:00 | N206-208 | Session: | St. Jude Medical Dinner Symposium - AF & VT Ablation Technologies | |
| Chair(s) | , | | |
| Topic 1. | Advanced ablation technologies for improved clinical outcomes (CoolFlex, Tacticath & 3Gi) | | |
| Topic 2. | Strategy for complex arrhythmia ablation (Precision) | | |
| Topic 3. | Future imaging technologies (Integrated Lab) | | |
| Atrial Fibrillation Ablation |
| 01-31 | 08:30-10:10 | N101A | Session: | Technical Aspects of AF Ablation | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | How to achieve permanent PV isolation using RF energy | | |
| Topic 2. | How to achieve permanent PV isolation using the cryoballoon | | |
| Topic 3. | How to present stroke and asymptomatic cerebral emboli during AF ablation | | |
| Topic 4. | How to map and ablate left atrial flutter post AF ablation | | |
| Topic 5. | How to safely perform a transseptal puncture without ICE | | |
| Sponsored Symposium |
| 01-31 | 08:30-10:10 | N104-105 | Session: | Biosense Webster - Back to Zero EP Course 1 | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Anatomic understanding and catheter manipulation in SVTs | | |
| Topic 2. | Differentiate diagnosis for complex SVTs | | |
| Oral Abstract Session |
| 01-31 | 08:30-10:10 | N109-110 | Session: | Heart Failure & Remote Patient Monitoring 1 | |
| Chair(s) | , | | |
| | , | | |
| Basic and Translational Science |
| 01-31 | 08:30-10:10 | N111-112 | Session: | The Fibrillating Heart | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | Localization of rotors in atrial fibrillation | | |
| Topic 2. | Body surface mapping in atrial fibrillation: technology and clinical application | | |
| Topic 3. | Arrhythmogenic cardiomyopathies | | |
| Topic 4. | Post-infarct denervation/reinnervation and arrhythmogenesis | | |
| HF Device & Monitoring |
| 01-31 | 08:30-10:10 | N201A | Session: | Heart Failure Device 3 | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Avoidance of phrenic nerve stimulation in CRT | | |
| Topic 2. | Optimization of AV intervals | | |
| Topic 3. | Remote monitoring of patients with ICDs and heart failure | | |
| Topic 4. | Endocardio LV pacing | | |
| Topic 5. | Optimal programming to reduce ICD shocks | | |
| VT Ablation |
| 01-31 | 08:30-10:10 | N201B | Session: | Outcome of VT Ablation | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | Mapping and ablation of intra-septal / intra mural VTs | | |
| Topic 2. | Programmed stimulation: results and their relation to long term survival | | |
| Topic 3. | Role of the NIPS (non-invasive programmed stimulation via the ICD) | | |
| Topic 4. | Epicardial and ablation technique for VTs | | |
| Topic 5. | Endpoint of VT ablation | | |
| Oral Abstract Session |
| 01-31 | 08:30-10:10 | N203 | Session: | Case Report 1 | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Arrhythmias in Congenital Hearts |
| 01-31 | 08:30-10:10 | N206-208 | Session: | Difficult Catheter Ablation for Adult Congenital Heart Disease | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | Catheter ablation for accessory pathway in complex heart anomalies | | |
| Topic 2. | Catheter ablation for AVNRT in complex heart anomalies | | |
| Topic 3. | Evaluating families after sudden death | | |
| Topic 4. | Molecular autopsy | | |
| Topic 5. | When are S-ICDs useful for primary prevention in channelopathies? | | |
| Oral Abstract Session |
| 01-31 | 08:30-10:10 | N211-212 | Session: | CSPE Best Abstract Award | |
| Chair(s) and Judge(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Atrial Fibrillation Ablation |
| 01-31 | 10:40-12:20 | N101A | Session: | Important Questions in the Field of AF Ablation? | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | Can AF ablation be performed safely in a patient on a NOAC without interruption? | | |
| Topic 2. | Can anticoagulation be stopped 2 months post successful ablation in a patient with a high stroke risk? | | |
| Topic 3. | Does targeting CFAEs improve outcomes of ablation or is this the wrong target? | | |
| Topic 4. | Should AF termination be the endpoint during ablation of long standing persistent AF? | | |
| Topic 5. | Does contact force monitoring improve outcomes of AF ablation? | | |
| Sponsored Symposium |
| 01-31 | 10:40-12:20 | N104-105 | Session: | Biosense Webster - Back to Zero EP Course 2 | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Ablation index and biophysics | | |
| Topic 2. | How to reduce fluoroscopy in SVTs with new techniques | | |
| Sudden Cardiac Death |
| 01-31 | 10:40-12:20 | N106-108 | Session: | Ventricular Arrhythmias in the General Population | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | Asian sudden cardiac death in heart failure (ASIAN-HF) registry | | |
| Topic 2. | Implications of the obesity and diabetes epidemics | | |
| Topic 3. | Gender differences in risk and prevention | | |
| Topic 4. | Role of risk markers using exercise testing in clinical workup for arrhythmias | | |
| Oral Abstract Session |
| 01-31 | 10:40-12:20 | N109-110 | Session: | Atrial Fibrillation (Ablation) 2 | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Neuro-modulation |
| 01-31 | 10:40-12:20 | N111-112 | Session: | Cardiac Neuraxial Targets to Modulate Arrhythmia Risk | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Cardiac intrinsic nervous system physiology and atrial arrhythmias | | |
| Topic 2. | Spinal cord stimulation in arrhythmia management | | |
| Topic 3. | The future arrhythmia management: Neuromodulation in perspective | | |
| Topic 4. | New results in autonomic modulation therapy for heart failure | | |
| Topic 5. | Renal denervation and post infarct ventricular arrhythmias | | |
| Atrial Fibrillation Drug |
| 01-31 | 10:40-12:20 | N201A | Session: | Managing Atrial Fibrillation in 2014: From Guidelines to Clinical Practice | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | New guidelines, new challenges | | |
| Topic 2. | Electrophysiology - what's new | | |
| Topic 3. | Screening and detection | | |
| Topic 4. | Stroke prevention | | |
| Topic 5. | Rate control, rhythm control, or both | | |
| VT Ablation |
| 01-31 | 10:40-12:20 | N201B | Session: | VT Ablation 2 | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Tips and tricks for epicardial puncture | | |
| Topic 2. | Precise location of ventricular outflow tract arrhythmias base on 12-lead ECG | | |
| Topic 3. | How to deal with fascicular VTs? | | |
| Topic 4. | Role of unipolar mapping in ventricular outflow track arrhythmia | | |
| Topic 5. | Catheter ablation for PMVT/VF | | |
| Oral Abstract Session |
| 01-31 | 10:40-12:20 | N203 | Session: | Case Report 2 | |
| Chair(s) | , | | |
| | , | | |
| Bradycardia Pacing |
| 01-31 | 10:40-12:20 | N206-208 | Session: | Technical Approaches to the Difficult Lead Extraction | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | Patient selection and pre-procedural evaluation | | |
| Topic 2. | Use of the laser | | |
| Topic 3. | Use of non-laser tools | | |
| Topic 4. | How to get and stay out of trouble | | |
| Topic 5. | Overview of the art: What lessons have we learned over the last ten years | | |
| Oral Abstract Session |
| 01-31 | 10:40-12:20 | N211-212 | Session: | Best Abstract Award | |
| Chair(s) and Judge(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| | , | | |
| | , | | |
| Sponsored Symposium |
| 01-31 | 12:20-13:50 | N101A | Session: | St. Jude Medical Lunch Symposium - The Future of Device Management | |
| Chair(s) | , | | |
| | , | | |
| Topic 1. | Leadless pacing | | |
| Topic 2. | CRT MultiPoint pacing - reducing non-responder rates | | |
| Topic 3. | Remote disease management (clinical data review) | | |
| Sponsored Symposium |
| 01-31 | 12:20-13:50 | N106-108 | Session: | Medtronic SCA Lunch Symposium | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Global Improve SCA trial | | |
| Topic 2. | SCA patient pathway protocol | | |
| Topic 3. | Role of MRI conditional ICDs | | |
| Sponsored Symposium |
| 01-31 | 12:20-13:50 | N201B | Session: | Biotronik Lunch Symposium - Advancing the Standard of Care for Patients with the use of Novel Technologies | |
| Chair(s) | , | | |
| | , | | |
| Topic 1. | Practical approaches in the management of ICD patients with BIOTRONIK home monitoring | | |
| Topic 2. | AF Management with BIOTRONIK DX system | | |
| EP Tracing |
| 01-31 | 13:50-15:30 | N101A | Session: | Interpretatino of Unknown Intracardiac Electrograms 1 | |
| Panelists | , | | |
| | , | | |
| | , | | |
| | , | | |
| | , | | |
| Oral Abstract Session |
| 01-31 | 13:50-15:30 | N104-105 | Session: | ECG; Classic, Complex and Unknown | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| ICD |
| 01-31 | 13:50-15:30 | N106-108 | Session: | ICD and Atrial Fibrillation | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Device choice and programming | | |
| Topic 2. | Impact of atrial fibrillation on outcomes | | |
| Topic 3. | Management of anticoagulation | | |
| Topic 4. | Chronotropic incompetence and rate control | | |
| Topic 5. | Atrial fibrillation and AV junction ablation for ICD and CRT patients | | |
| Special Session |
| 01-31 | 13:50-15:30 | N109-110 | Session: | Video Case Presentation | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Case 1 | | |
| Topic 2. | Case 2 | | |
| Allied Professionals Program |
| 01-31 | 13:50-15:30 | N111-112 | Session: | Basic Electrophysiology | |
| Chair(s) | , | | |
| | , | | |
| Topic 1. | ECG for allied professionals | | |
| Topic 2. | Brady-arrhythmias | | |
| Topic 3. | Tachy-arrhythmias | | |
| Topic 4. | Non-invasive investigations of rhythm disorders | | |
| Topic 5. | Chain of Survival | | |
| Atrial Fibrillation Ablation |
| 01-31 | 13:50-15:30 | N201A | Session: | Progress in Ablation of AF | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | New generation high output/alternative energy sources for the ablation of AFh | | |
| Topic 2. | Ganglionated plexi ablation: appraisal of risks and benefits | | |
| Topic 3. | Extracorporeal carbon particle therapy for ablating atrial arrhythmias | | |
| Topic 4. | High-density mapping and ablation of complex atrial tachyardia | | |
| Topic 5. | Innovations in EP mapping and ablation catheters | | |
| VT Ablation |
| 01-31 | 13:50-15:30 | N201B | Session: | (VT Ablation 3) | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Strategies for substrate ablation: homogenization, LAVA/late potentials, linear lesions? | | |
| Topic 2. | Mapping of Brugada syndrome | | |
| Topic 3. | Substrate based techniques only during sinus rhythm: how reliable is this? | | |
| Topic 4. | Management of hemodynamic unstable VTs | | |
| Topic 5. | New technology for intramural VTs | | |
| Oral Abstract Session |
| 01-31 | 13:50-15:30 | N203 | Session: | Atrial Fibrillation: New Insights and Mechanisms 1 | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Atrial Fibrillation Device |
| 01-31 | 13:50-15:30 | N206-208 | Session: | How to Manage AF Patients with Devices | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | When to anticoagulate asymptomatic AF on device datalogs | | |
| Topic 2. | Optimize ICD device programming to avoid inappropriate AF shocks | | |
| Topic 3. | When to choose AF ablation vs AV node ablation vs amiodarone in ICD subjects | | |
| Topic 4. | When to perform AV node ablation in CRT patients with Afib | | |
| Topic 5. | How best to manage anticoagulation during CIED procedures | | |
| Topic 6. | Optimizing CRT function among patients with AF | | |
| CSPE Session |
| 01-31 | 13:50-15:30 | N211-212 | Session: | EP Part | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | The value of high density mapping and contact force monitoring on radiofrequency ablation of AF | | |
| Topic 2. | Accelerated ventricular rhythm from His-purkinje system: benign or insidious | | |
| Topic 3. | Left atrial appendage occlusion in China | | |
| Topic 4. | Cryoablation for treatment of paroxysmal atrial fibrillation: experience from Ruijin Hospital | | |
| Topic 5. | Scn5a screening might predispose to VT/VF after lidocaine administration in the setting of myocardial ischemia | | |
| EP Tracing |
| 01-31 | 16:00-17:40 | N101A | Session: | Interpretation of Unknown Intracardiac Electrograms 2 | |
| Panelists | , | | |
| | , | | |
| | , | | |
| | , | | |
| | , | | |
| Surgical Therapy and Device |
| 01-31 | 16:00-17:40 | N104-105 | Session: | Arrhythmia Surgery | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | Long-term outcome after Maze procedure with mitral valve surgery | | |
| Topic 2. | LA function after surgical procedure | | |
| Topic 3. | Concomitant valve surgery and AF surgery | | |
| Topic 4. | Surgery for non-ischemic VT | | |
| Topic 5. | Long-term outcomes after AF Ablation: catheter vs. surgery | | |
| Topic 6. | Minimally invasive mitral and AF surgery | | |
| ICD |
| 01-31 | 16:00-17:40 | N106-108 | Session: | Tachycardia Device Outcomes | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | ICD programming to improve outcomes | | |
| Topic 2. | Risk stratification for primary prevention | | |
| Topic 3. | When and how to use subcutaneous ICD therapy | | |
| Topic 4. | CIED deactivation | | |
| Topic 5. | Creative and alternative venous access for implantation | | |
| Sponsored Symposium |
| 01-31 | 16:00-17:40 | N109-110 | Session: | Medtronic Atrial Fibrillation Symposium | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Early experience of cryoablation in China | | |
| Topic 2. | Tips and tricks of using 1st generation cryoballoon | | |
| Topic 3. | AF ablation with 2nd generation cryoballoon | | |
| Allied Professionals Program |
| 01-31 | 16:00-17:40 | N111-112 | Session: | Basic Devices | |
| Chair(s) | , | | |
| | , | | |
| Topic 1. | Anti-arrhythmias drugs | | |
| Topic 2. | Electrophysiology study: when, why and how? | | |
| Topic 3. | Catheter ablation: principles and application | | |
| Topic 4. | Cardioversion and tilt table testing: nursing perspectives | | |
| Topic 5. | Overview of implantable cardiac devices | | |
| Atrial Fibrillation Ablation |
| 01-31 | 16:00-17:40 | N201A | Session: | A New Generation of Approaches | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | Linear cold balloon therapy for persistent atrial fibrillation | | |
| Topic 2. | Impact of contact force ablation on clinical outcomes in patients with atrial fibrillation | | |
| Topic 3. | 4-5 D mapping for ablation of AF rotors to drivers | | |
| Topic 4. | The biophysics of new generation cryoballoon and contact force ablative intervention | | |
| Topic 5. | Pulmonary antrum radial-linear ablation | | |
| SVT Ablation |
| 01-31 | 16:00-17:40 | N201B | Session: | SVT Ablation 1 | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | De novo atypical atrial flutters | | |
| Topic 2. | Ablation of atriofascicular pathways | | |
| Topic 3. | Ablation of AT post AF ablation | | |
| Topic 4. | Atrial arrhythmias in repaired congenital heart disease | | |
| Oral Abstract Session |
| 01-31 | 16:00-17:40 | N203 | Session: | Bradycardia Pacing | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Lead Management/ Extraction |
| 01-31 | 16:00-17:40 | N206-208 | Session: | Infection and Extraction | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Incidence, risks and detection of device infection | | |
| Topic 2. | Understanding bacteria and biofilms | | |
| Topic 3. | Outcomes of patients with device infections | | |
| Topic 4. | Extraction approaches to infected devices | | |
| Topic 5. | Best practices in prevention and treatment of infections | | |
| CSPE Session |
| 01-31 | 16:00-17:40 | N211-212 | Session: | Anticoagulation of AF | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | The present situation and problems of atrial fibrillation anticoagulation in China | | |
| Topic 2. | Application of new oral anticoagulant for patients with non-valvular atrial fibrillation - consensus of Chinese experts | | |
| Topic 3. | Antithrombotic therapy for the atrial fibrillation in patients with acute coronary syndrome | | |
| Topic 4. | Antithrombotic therapy for the atrial fibrillation patients in perioperative or postoperative period of radiofrequency ablation | | |
| Topic 5. | Does the subclinical atrial fibrillation recorded by pacemaker need antithrombotic therapy? | | |
| Special Session |
| 01-31 | 18:00-18:30 | N101A | Session: | Opening Ceremony | |
| Topic 1. | Officiated by Guest-of-Honor: Wing-Man KO, BBS, JP, Secretary for Food and Health, HKSAR Government | | |
| Special Session |
| 01-31 | 18:30-19:00 | N101A | Session: | Sun Chieh Yeh Heart Foundation Lecture | |
| Chair(s) | , | | |
| | , | | |
| Topic 1. | Stroke and bleeding risks in atrial fibrillation: What can we learn from registries? | | |
| Practical Arrhythmia Management for Clinicians |
| 02-01 | 08:30-10:10 | N101A | Session: | ECG and Case Studies: How to Approach Such Arrhythmia? | |
| Chair(s) | , | | |
| | , | | |
| Topic 1. | ECG interpretation | | |
| Topic 2. | Bradycardia | | |
| Topic 3. | Narrow complex tachycardia | | |
| Topic 4. | Wide complex tachycardia | | |
| Atrial Fibrillation in Structural Heart Diseases |
| 02-01 | 08:30-10:10 | N104-105 | Session: | Atrial Fibrillation in Structural Heart Diseases: How Best to Manage? | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | The patient with heart failure | | |
| Topic 2. | The patient with valvular heart disease | | |
| Topic 3. | The patient with "lone" AF | | |
| Topic 4. | The patient with congenital heart disease | | |
| Bradycardia Pacing |
| 02-01 | 08:30-10:10 | N106-108 | Session: | Clinical Trials Update | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | Lessons from MADIT CRT | | |
| Topic 2. | Lesson from MADIT RIT | | |
| Topic 3. | Lessons from BLOCK HF | | |
| Topic 4. | Lessons from MINVERVA | | |
| Topic 5. | Lessons from IN-TIME | | |
| Genetic Counselling for Inherited Cardic Arrhythmia |
| 02-01 | 08:30-10:10 | N109-110 | Session: | Approach to Genetic Counselling for Inherited Cardiac Arrhythmias | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | Overview of management and outcomes in sudden death survivors with channelopathies | | |
| Topic 2. | Arrhythmia risk assessment in asymptomatic family members | | |
| Topic 3. | Arrhythmia reduction strategies in inherited arrhythmias | | |
| Topic 4. | Long-term follow up and management of patients with inherited channelopathies | | |
| Allied Professionals Program |
| 02-01 | 08:30-10:10 | N111-112 | Session: | Advanced Electrophysiology | |
| Chair(s) | , | | |
| | , | | |
| Topic 1. | Cardiac anatomy and the conduction system | | |
| Topic 2. | Overview of CARTO mapping | | |
| Topic 3. | Overview of Ensite mapping | | |
| Topic 4. | Application of cryoablation | | |
| Topic 5. | Techniques of transeptal puncture | | |
| Oral Abstract Session |
| 02-01 | 08:30-10:10 | N203 | Session: | Atrial Fibrillation (Ablation) 3 | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Lead Management/ Extraction |
| 02-01 | 08:30-10:10 | N206-208 | Session: | Lead Extraction | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | Trans femoral approach of lead extraction | | |
| Topic 2. | When and how each tool is useful | | |
| Topic 3. | Knowing when to say no or stop | | |
| Topic 4. | Coronary sinus lead extraction | | |
| Topic 5. | Managing vegetations in device patients | | |
| CSPE Session |
| 02-01 | 08:30-10:10 | N211-212 | Session: | Implanted Device | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | The application of cardiac implantable devices in China-2014 | | |
| Topic 2. | Primary prevention of sudden cardiac death- China Registry | | |
| Topic 3. | The developments in cardiac-pacing in China | | |
| Topic 4. | Progress of cardiac contractility modulation in the therapy of heart failure | | |
| Topic 5. | If CRT based on pace-making of the left ventricle can bring additional benefits | | |
| Topic 6. | A application of remote monitoring of cardiac pacemaker in China | | |
| Implanted Device |
| 02-01 | 08:30-10:10 | N211-212 | Session: | CSPE Session III | |
| Topic 1. | The application of cardiac implantable devices in China--2014 | | |
| Topic 2. | Primary prevention of sudden cardiac death--China Registry | | |
| Topic 3. | The developments in cardiac-pacing in China | | |
| Topic 4. | Progress of cardiac contractility modulation in the therapy of heart failure | | |
| Topic 5. | If the CRT based on the pace-making of left ventricle can bring additional benefits | | |
| Topic 6. | The application of remote monitoring of cardiac pacemaker in China | | |
| Sudden Cardiac Death |
| 02-01 | 08:30-10:10 | N211-212 | Session: | CSPE Session IV | |
| Topic 1. | Prevention of sudden death in hypertrophic cardio myopathy: updated guidelines | | |
| Topic 2. | Prevention of sudden cardiac death in non-ischemic cardiomyopathy | | |
| Topic 3. | Predictive factors of sudden cardiac death for post myocardial patients with heart failure | | |
| Topic 4. | Research progress on hereditary arrhythmia | | |
| Topic 5. | Progress in treatment of idiopathic ventricular fibrillation | | |
| Topic 6. | Treatment for arrhythmogenic cardiomyopathy RFCA or ICD | | |
| Practical Arrhythmia Management for Clinicians |
| 02-01 | 10:40-12:20 | N101A | Session: | How would you Manage this Patient? | |
| Chair(s) | , | | |
| | , | | |
| Topic 1. | An elderly patient who fainted | | |
| Topic 2. | A sleep apnea patient with cardiomegaly | | |
| Topic 3. | A patient with palpitation and tones of ectopics | | |
| Topic 4. | A cancer patient with an ICD | | |
| Atrial Fibrillation Drug |
| 02-01 | 10:40-12:20 | N104-105 | Session: | Drugs for Atrial Fibrillation: the Good, the Bad and the Ugly | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | What or who are we treating? | | |
| Topic 2. | Drugs for pharmacological cardioversion: the old, the new and the future | | |
| Topic 3. | Sinus conversion of persistent AF by Bepridil | | |
| Topic 4. | Rate control with digoxin: safe or not? | | |
| Topic 5. | Stroke prevention in atrial fibrillation: pharmacological and non-pharmacological approaches | | |
| Atrial Fibrillation Device |
| 02-01 | 10:40-12:20 | N106-108 | Session: | AF and CIEDS | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | What is the prognostic importance of AF documented on device datalogs | | |
| Topic 2. | Role of loop-recorder in evaluation of cryptogenic stroke | | |
| Topic 3. | Prognostic importance of AF among ICD patients | | |
| Topic 4. | Role of ATP and MVP in preventing AF | | |
| Sponsored Symposium |
| 02-01 | 10:40-12:20 | N109-110 | Session: | Medtronic - Radiology and MRI Implantable Cardiac Devices Symposium | |
| Topic 1. | MRI conditional device update | | |
| Topic 2. | Cardiologist perspective | | |
| Topic 3. | Radiologist perspective | | |
| Topic 4. | MRI conditional device programming pre/post MRI | | |
| Allied Professionals Program |
| 02-01 | 10:40-12:20 | N111-112 | Session: | Advanced Devices | |
| Chair(s) | , | | |
| | , | | |
| Topic 1. | Conscious sedation in the EP lab | | |
| Topic 2. | Implantation and follow up of pacemakers | | |
| Topic 3. | Implantation and follow up of CRT devices | | |
| Topic 4. | Implantation and follow up of ICD | | |
| Topic 5. | Remote monitoring of implantable cardiac devices | | |
| Sudden Cardiac Death |
| 02-01 | 10:40-12:20 | N203 | Session: | State of the Art for Familial Arrhythmia Syndromes: Long QT, Brugada, CPVT, HCM, ARVD | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | Risk markers on the 12-lead ECG | | |
| Topic 2. | Clinical approach to genetic testing and counselling | | |
| Topic 3. | Role of drug therapy | | |
| Topic 4. | Role of catheter ablation | | |
| CRT |
| 02-01 | 10:40-12:20 | N206-208 | Session: | (CRT Workshop 2) | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | Effect of pacing sites on CRT responses | | |
| Topic 2. | Should CRT be used in RBBB subjects? | | |
| Topic 3. | Optimizing CRT-D programming to minimize shocks | | |
| Topic 4. | A new paradigm in CRT - adaptive CRT clinical evidence | | |
| CSPE Session |
| 02-01 | 10:40-12:20 | N211-212 | Session: | Sudden Cardiac Death | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
| | , | | |
| | , | | |
| Topic 1. | Risk of sudden death in hypertrophic cardiomyopathy and ICD therapy | | |
| Topic 2. | Prevention of sudden cardiac death in nonischemic cardiomyopathy | | |
| Topic 3. | Predictive factors of sudden cardiac death for post myocardial infarction patients with heart failure | | |
| Topic 4. | Research progress on hereditary arrhythmia | | |
| Topic 5. | Progress in treatment of idiopathic ventricular fibrillation | | |
| Topic 6. | Treatment for arrhythmogenic cardiomyopathy: RFCA or ICD? | | |
| Sponsored Symposium |
| 02-01 | 12:20-13:50 | N101A | Session: | Boehringer Ingelheim Lunch Symposium | |
| Chair(s) | , | | |
| | , | | |
| Topic 1. | Evidences of NOACs in SPAF: past, present and future | | |
| Topic 2. | Stroke management in NOAC patients: from acute presentation to recovery | | |
| Sponsored Symposium |
| 02-01 | 12:20-13:50 | N106-108 | Session: | Boston Scientific Lunch Symposium | |
| Chair(s) | , | | |
| | , | | |
| Topic 1. | Subcutaneous ICD: simplicity in complexity | | |
| Topic 2. | Mapping and ablating using the high density Rhythmia™ system | | |
| Topic 3. | True tip location ablation with MiFi™ micro fidelity electrodes | | |
| Practical Arrhythmia Management for Clinicians |
| 02-01 | 13:50-15:30 | N101A | Session: | Update on Implantable Cardiac Devices | |
| Chair(s) | , | | |
| | , | | |
| Topic 1. | Contemporary implantable cardiac electronic devices | | |
| Topic 2. | Recent advances in bradycardia pacing | | |
| Topic 3. | Recent advances in implantable defibrillator | | |
| Topic 4. | Recent advances in cardiac resynchronization therapy | | |
| Atrial Fibrillation Drug |
| 02-01 | 13:50-15:30 | N104-105 | Session: | How to Use NOACs for Stroke Prevention in Atrial Fibrillation: Practical Tips | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Choosing the right NOAC for the right patient: one drug for all? | | |
| Topic 2. | Do we need to treat Asian patients differently | | |
| Topic 3. | The patient who is bleeding or requiring surgery: is a NOAC antidote needed | | |
| Topic 4. | The patient presenting with an acute coronary syndrome and/or requiring stenting | | |
| Topic 5. | Ensuring compliance and treatment adherence | | |
| SVT Ablation |
| 02-01 | 13:50-15:30 | N106-108 | Session: | SVT Ablation 2 | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Diagnostic maneuvers for SVT/AVNRT/accessory pathwayss | | |
| Topic 2. | Do we need 3D mapping for SVT ablation? | | |
| Topic 3. | Ablation of atriofascicular pathways | | |
| Topic 4. | Cool Flex irrigation tip atrial flutter ablation | | |
| Oral Abstract Session |
| 02-01 | 13:50-15:30 | N109-110 | Session: | Basic Research | |
| Chair(s) | , | | |
| | , | | |
| Oral Abstract Session |
| 02-01 | 13:50-15:30 | N203 | Session: | Case Report 3 | |
| Chair(s) | , | | |
| | , | | |
| Pacing |
| 02-01 | 13:50-15:30 | N206-208 | Session: | Device Workshop: Analysis of Advanced Device Function | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Topic 1. | Analysis of complex CRT tracings | | |
| Topic 2. | Analysis of complex pacemaker tracings | | |
| Topic 3. | Analysis of different ICD device algorithms | | |
| Oral Abstract Session |
| 02-01 | 13:50-15:30 | N211-212 | Session: | Heart Failure & Remote Patient Monitoring 2 | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| Practical Arrhythmia Management for Clinicians |
| 02-01 | 16:00-17:40 | N101A | Session: | Atrial Fibrillation | |
| Chair(s) | , | | |
| | , | | |
| Topic 1. | How to decide on rate or rhythm control? | | |
| Topic 2. | Who and when should you refer for AF ablation? | | |
| Topic 3. | Who needs antithrombotic treatment? | | |
| Topic 4. | How to deal with a patient on novel anticoagulant when they develop other medical issues? | | |
| Oral Abstract Session |
| 02-01 | 16:00-17:40 | N111-112 | Session: | Atrial Fibrillation: New Insights and Mechanisms 2 | |
| Chair(s) | , | | |
| | , | | |
| | , | | |
| | , | | |
